SUPPORTED
DMT has been reported in human body fluids. Detection establishes presence, not a psychoactive role during dying.
Channelled Records · Claim Queue · CQ-005 · v0.1.0
CQ-005
Endogenous DMT.
Possible contributor—not established cause.
Is endogenous DMT sufficient to explain any defined class of near-death experience? The molecule, the measured concentration, the physiological timing, the experience and the proposed mechanism must be evaluated separately.
BIOCHEMICAL HYPOTHESIS · INSUFFICIENT HUMAN EVIDENCE. Endogenous presence and drug-induced similarity make the idea testable. They do not establish a psychoactive human surge during dying or show that DMT is necessary or sufficient for NDEs.
Claim-level evidence profile
Five links.
Only some are supported.
ANIMAL EVIDENCE
Rat studies support brain synthesis and report increased cortical DMT after experimental cardiac arrest. Human near-death concentrations remain unmeasured.
SUPPORTED WITH LIMITS
Administered DMT can produce NDE-like questionnaire scores and motifs, but later detailed comparisons also identify substantial differences.
NOT ESTABLISHED
No direct human evidence currently shows a near-death surge reaching psychoactive brain concentrations at the time an NDE is formed.
NOT DEMONSTRATED
The existing evidence does not establish endogenous DMT as necessary or sufficient for any defined class of NDE.
Inference ladder
Do not leap
from molecule to mechanism.
| Step | Question | Current answer |
|---|---|---|
| PRESENCE | Is DMT detectable in humans? | Yes, across historical body-fluid studies, with variable methods and results. |
| RELEASE | Does DMT increase during human dying? | Unknown. The cardiac-arrest increase reported to date is from rats. |
| CONCENTRATION | Could any human increase be psychoactive? | Unknown. Relevant time-resolved human brain concentrations have not been demonstrated. |
| SIMILARITY | Can administered DMT feel NDE-like? | Yes, for several broad features; detailed content also diverges. |
| CAUSATION | Does similarity establish the cause of NDEs? | No. Similar experiences can arise through overlapping downstream systems without sharing one initiating mechanism. |
Evidence and counter-evidence
Detection, animal biology
and human phenomenology.
2012 · Barker, McIlhenny & Strassman
A critical review examined 69 studies reporting endogenous DMT, 5-HO-DMT or 5-MeO-DMT in human blood, urine or cerebrospinal fluid and highlighted major methodological limitations.
HUMAN DETECTION REVIEW ↗2018 · Nichols
A critical review found scientific evidence inconsistent with popular claims that the pineal gland releases enough DMT at birth, during dreams or near death to cause these experiences.
MECHANISTIC CRITIQUE ↗2018 · Timmermann et al.
In 13 healthy volunteers, administered DMT produced substantially higher NDE-scale scores than placebo and broad phenomenological overlap with recalled NDE reports.
SMALL PLACEBO-CONTROLLED STUDY ↗2019 · Dean et al.
Rat brains expressed relevant synthetic machinery and extracellular cortical DMT increased after experimental cardiac arrest, including in animals without an intact pineal gland.
ANIMAL CARDIAC-ARREST EVIDENCE ↗2025 · Michael, Luke & Robinson
A qualitative comparison of 36 naturalistic DMT accounts and 34 NDE narratives found shared basic structure but important differences in content and sequence, describing DMT as NDE-mimetic rather than equivalent.
PHENOMENOLOGY · CONVERGENCE + DIVERGENCE ↗Minimum discriminating pathway
Measure the molecule.
Synchronise the experience.
DEFINE THE NDE CLASS
Predefine clinical context, physiology, report timing and experiential features instead of treating every NDE as one phenomenon.
MEASURE PROSPECTIVELY
Use validated, contamination-controlled assays with the tightest ethically possible sampling around resuscitation and recovery.
ALIGN THE CLOCKS
Synchronise sampling with continuous physiology, medication, oxygenation, circulation, EEG where available and the first recoverable report.
ASSESS BLINDLY
Have assessors score NDE content without knowing biomarker results, clinical outcome or the proposed DMT explanation.
COMPARE SPECIFIC CONTENT
Go beyond total questionnaire scores to sequence, life review, deceased persons, tunnels, entities, emotion, memory and absent features.
STATE FALSIFIERS
Specify what null concentrations, mismatched timing, negative cases or competing biomarkers would count against the hypothesis.
Relationship to BQ001
A biochemical contribution
would not settle continuity.
If future evidence implicated endogenous DMT in some NDE features, that could explain part of their neurobiology without deciding whether every feature is reducible to that mechanism. If the hypothesis failed, survival would not follow by default. BQ001 remains unresolved.